Ignite Creation Date:
2025-12-24 @ 11:31 PM
Ignite Modification Date:
2026-01-02 @ 3:52 AM
Study NCT ID:
NCT04919356
Status:
TERMINATED
Last Update Posted:
2023-01-18
First Post:
2021-06-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Parkinson's Disease G2019S LRRK2 Genetic Testing Program
Sponsor:
Escape Bio, Inc.
Organization:
Study Overview
Official Title:
G2019S LRRK2 Parkinson's Disease: Increasing Awareness and Genetic Testing Program
Status:
TERMINATED
Status Verified Date:
2022-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Sponsor stopped the study
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Increase awareness of the G2019S LRRK2 mutation in Parkinson's and no cost genetic testing program.
Detailed Description:
This program is intended to increase awareness of genetic Parkinson's, in particular the G2019S LRRK2 mutation, and provide no cost genetic testing to determine if they carry the G2019S LRRK2 mutation.
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: